Inactief instrument

Koers Merus Labs International Inc

Aandelen

Duur

Periode

Stijl

Merus Labs International : Norgine B.V. completes acquisition of Merus Labs International Inc. strengthening its leading position in the European specialist pharma market	17-07-17
Merus Labs International : Receives Court Approval in Connection with Proposed Plan of Arrangement with Norgine B.V.	13-07-17
Merus Labs International : Shareholders Approve Plan of Arrangement with Norgine B.V.	10-07-17
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement of Fiscal Q1 2017 Earnings Release	04-07-17
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement	04-07-17

Sector

	Vaira. 1 jan.	Kapi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21,28%	44,4 mld.
OTSUKA HOLDINGS CO., LTD.	+24,28%	23,03 mld.
SANDOZ GROUP AG	+19,22%	15,14 mld.
CIPLA LIMITED	+12,87%	13,12 mld.
ZYDUS LIFESCIENCES LIMITED	+44,67%	11,85 mld.
ONO PHARMACEUTICAL CO., LTD.	-10,02%	6,99 mld.
THE MEDICINES COMPANY	-0,05%	6,79 mld.
STADA ARZNEIMITTEL	-8,87%	5,73 mld.
ASPEN PHARMACARE HOLDINGS LIMITED	+13,07%	5,52 mld.